News

Learn more about CTMC’s progress in accelerating cell therapy development and manufacturing to reach patients faster.

Press Releases

September 13, 2022

Ori Biotech and CTMC partner to accelerate novel cell therapy delivery

June 17, 2022

CTMC, Invectys, and MD Anderson announce strategic collaboration for CAR T cell therapy development

In the News

December 21, 2022

Invectys and CTMC announce FDA clearance of IND application for anti-HLA-G CAR-T cell therapy

September 15, 2022

Ori Biotech taps MD Anderson, National Resilience joint venture to put its automated cell and gene therapy manufacturing tech to the test

June 16, 2022

CTMC, Invectys, and MD Anderson announce strategic collaboration for CAR T cell therapy development

June 6, 2022

Endpoints News: Resilience forges JV with MD Anderson, readying new cell therapies for cancer

June 3, 2022

Fierce Pharma: National Resilience teams with MD Anderson to add cell therapy JV to its bustling biomanufacturing network.

June 2, 2022

MD Anderson and Resilience launch joint venture to accelerate development and manufacturing of innovative cell therapies for cancer

June 2, 2022

Resilience and MD Anderson Launch Joint Venture to Accelerate Development and Manufacturing of Innovative Cell Therapies for Cancer

April 15, 2021

TIL Therapy: Six Things to Know

November 18, 2020

MD Anderson and Obsidian Therapeutics announce strategic collaboration to accelerate advancement of novel engineered tumor infiltrating lymphocyte therapy (cytoTIL™) for solid tumors

January 21, 2020

MD Anderson accelerates cellular therapy programs by buying state-of-art manufacturing facility

For Press Inquiries Contact